Growth in precocious puberty

Indian Journal of Pediatrics

Volumn 73, Issue 1, 2006, Pages 81-88

  Brown, Justin J ^a   Warne, Garry L ^b,c  

^a MURDOCH CHILDREN'S RESEARCH INSTITUTE   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c ROYAL CHILDREN'S HOSPITAL   (Australia)

Author keywords

Gonadotrophin releasing hormone; Growth; Height; Precocious puberty

Indexed keywords

CALCIUM; GESTAGEN; GONADOTROPIN;

ALLERGIC REACTION; BODY HEIGHT; BONE DENSITY; BONE MASS; CLINICAL TRIAL; CONFERENCE PAPER; CONGENITAL ADRENAL HYPERPLASIA; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DELAYED PUBERTY; HEADACHE; HOT FLUSH; HUMAN; HYPOTHYROIDISM; MEDICAL LITERATURE; MEDICAL SOCIETY; NAUSEA; OBESITY; PUBLICATION; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; WEIGHT GAIN; ARTICLE; CHILD; CHILD DEVELOPMENT; DRUG EFFECT; FEMALE; GROWTH; GROWTH DISORDER; MALE; PHYSIOLOGY; PRECOCIOUS PUBERTY;

CHILD; CHILD DEVELOPMENT; FEMALE; GROWTH; GROWTH DISORDERS; HUMANS; MALE; OBESITY; PUBERTY, PRECOCIOUS;

EID: 33745962061     PISSN: 00195456     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02758267     Document Type: Conference Paper

References (74)

1. Marshall WA, Tanner JM. Variations in the pattern of pubertal changes in girls. Arch Dis Child 1969; 44(235) : 291-303.
2. Marshall WA, Tanner JM. Variations in the pattern of pubertal changes in boys. Arch Dis Child 1970; 45(239) : 13-23.
3. Herman-Giddens ME, Slora EJ, Wasserman RC, Bourdony CJ, Bhapkar MV, Koch GG, Hasemeier CM. Secondary sexual characteristics and menses in young girls seen in office practice: a study from the Pediatric Research in Office Settings network. Pediatrics 1997; 99(4) : 505-512.
4. Kaplowitz PB and Oberfield SE. Reexamination of the age limit for defining when puberty is precocious in girls in the United States: implications for evaluation and treatment. Drug and Therapeutics and Executive Committees of the Lawson Wilkins Pediatric Endocrine Society. Pediatrics 1999; 104(4 Pt 1) : 936-941.
5. Klein KO. Precocious puberty: who has it? Who should be treated? J Clin Endocrinol Metab 1999; 84(2) : 411-414.
6. Mul D, Fredriks AM, van Buuren S, Oostdijk W, Verloove-Vanhorick SP, Wit JM. Pubertal development in The Netherlands 1965-1997. Pediatr Res 2001; 50(4) : 479-486.
7. Midyett LK, Moore WV, Jacobson JD. Are pubertal changes in girls before age 8 benign? Pediatrics 2003; 111(1) : 47-51.
8. Lindgren G. Pubertal stages 1980 of Stockholm schoolchildren. Acta Paediatr 1996; 85(11) : 1365-1367.
9. Huen KF, Leung SS, Lau JT, Cheung AY, Leung NK, Chiu MC. Secular trend in the sexual maturation of southern Chinese girls. Acta Paediatr 1997; 86(10) : 1121-1124.
10. Thomas F, Renaud F, Benefice E, de Meeus T, Guegan JF. International variability of ages at menarche and menopause: patterns and main determinants. Hum Biol 2001; 73 : 271-290.
11. Parent AS, Teilmann G, Juul A, Skakkebaek NE, Toppari J, Bourguignon JP. The timing of normal puberty and the age limits of sexual precocity: variations around the world, secular trends, and changes after migration. Endocr Rev 2003; 24(5) : 668-693.
12. Wang Y. Is obesity associated with early sexual maturation? A comparison of the association in American boys and girls. Pediatrics 2002; 110 : 903-909.
13. Kaplowitz PB, Slora EJ, Wasserman RC, Pedlow SE, Herman-Giddens ME. Earlier onset of puberty in girls: relation to increased body mass index and race. Pediatrics 2001; 108(2) : 347-353.
14. Kappy MS, Ganong CS. Advances in the treatment of precocious puberty. Adv Pediatr 1994; 41 : 223-261.
15. Cisternino M, Arrigo T, Pasquino AM, Tinelli C, Antoniazzi F, Beduschi L, Bindi G, Borrelli P, De Sanctis V, Farello G, Galluzzi F, Gargantini L, Lo Presti D, Sposito M, Tato L. Etiology and age incidence of precocious puberty in girls: a multicentric study. J Pediatr Endocrinol Metab 2000; 13 Suppl 1 : 695-701.
16. De Sanctis V, Corrias A, Rizzo V, Bertelloni S, Urso L, Galluzzi F, Pasquino AM, Pozzan G, Guarneri MP, Cisternino M, De Luca F, Gargantini L, Pilotta A, Sposito M, Tonini G. Etiology of central precocious puberty in males: the results of the Italian Study Group for Physiopathology of Puberty. J Pediatr Endocrinol Metab 2000; 13 Suppl 1 : 687-693.
17. Pescovitz OH, Comite F, Hench K, Barnes K, McNemar A, Foster C, Kenigsberg D, Loriaux DL, Cutler GB Jr. The NIH experience with precocious puberty: diagnostic subgroups and response to short-term luteinizing hormone releasing hormone analogue therapy. J Pediatr 1986; 108(1) : 47-54.
18. Thamdrup E. 1961. Precocious sexual development. A clinical study of 100 children. Copenhagen; Munksgaard, 104-105.
19. Grunt JA, Midyett LK, Simon SD, Lowe L. When should cranial magnetic resonance imaging be used in girls with early sexual development? J Pediatr Endocrinol Metab 2004; 17(5) : 775-780.
20. Anasti JN, Flack MR, Froeloich J et al. A potential novel mechanism for precocious puberty in juvenile hypothyroidism. J Clin Endocrinol Metab 1995; 80 : 276-279.
21. Van Wyk JJ, Grumbach MM. Syndrome of precocious menstruation and galactorrhea in juvenile hypothyroidism: An example of hormonal overlap in pituitary feedback. J Pediatr 1960; 57 : 416-435.
22. Chattopadhyay A, Kumar V, Marulaiah M. Polycystic ovaries, precocious puberty and acquired hypothyroidism: The Van Wyk and Grumbach syndrome. J Pediatr Surg 2003; 38(9) : 1390-1392.
23. Bourguignon JP, Gerard A, Alvarez Gonzalez ML, Fawe L, Franchimont P. Effects of changes in nutritional conditions on timing of puberty: clinical evidence from adopted children and experimental studies in the male rat. Horm Res 1992; 38 Suppl 1:97-105.
24. Adolfson S, Westphal O. Early pubertal development in girls adopted from Far Eastern countries. Pediatr Res 1981; 15; 82 (abstract).
25. Bajpai A, Sharma J, Kabra M, Kumar Gupta A, Menon PS. Precocious puberty: clinical and endocrine profile and factors indicating neurogenic precocity in Indian children. J Pediatr Endocrinol Metab 2002; 15(8) : 1173-1181.
26. Carel JC, Chaussain JL. Gonadotropin releasing hormone agonist treatment for central precocious puberty. Horm Res 1999; 51 Suppl 3:64-9.
27. Pescovitz OH, Hench KD, Barnes KM, Loriaux DL, Cutler GB Jr. Premature thelarche and central precocious puberty: the relationship between clinical presentation and the gonadotropin response to luteinizing hormone-releasing hormone. J Clin Endocrinol Metab 1988; 67(3) : 474-479.
28. Neely EK, Hintz RL, Wilson DM, Lee PA, Gautier T, Argente J, Stene M. Normal ranges for immuno-che-miluminometric gonadotropin assays. J Pediatr 1995;127(1) : 40-46.
29. Kaplan SL, Grumbach MM. Clinical review 14: Pathophysiology and treatment of sexual precocity. J Clin Endocrinol Metab 1990; 71(4) : 785-789.
30. Leger J, Reynaud R, Czernichow P. Do all girls with apparent idiopathic precocious puberty require gonadotropin-releasing hormone agonist treatment? J Pediatr 2000; 137(6) : 819-825.
31. Rosenfield RL. Selection of children with precocious puberty for treatment with gonadotropin releasing hormone analogs. J Pediatr 1994; 124(6) : 989-991.
32. Kvale G, Heuch I. Menstrual factors and breast cancer risk. Cancer 1988; 62(8) : 1625-1631.
33. Gao YT, Shu XO, Dai Q, Potter JD, Brinton LA, Wen W, Sellers TA, Kushi LH, Ruan Z, Bostick RM, Jin F, Zheng W. Association of menstrual and reproductive factors with breast cancer risk: results from the Shanghai Breast Cancer. Study Int J Cancer 2000; 87(2) : 295-300.
34. Ahlgren M, Melbye M, Wohlfahrt J, Sorensen TI. Growth patterns and the risk of breast cancer in women. N Engl J Med 2004; 351(16) : 1619-1626.
35. Bayley N, Pinneau SR. Tables for predicting adult height from skeletal age: revised for use with the Greulich-Pyle hand standards. J Pediatr 1952; 40(4) : 423-441.
36. Antoniazzi F, Cisternino M, Nizzoli G, Bozzola M, Corrias A, De Luca F, De Sanctis C, Rigon F, Zamboni G, Bernasconi S et al. Final height in girls with central precocious puberty: comparison of two different luteinizing hormone-releasing hormone agonist treatments. Acta Paediatr 1994; 83(10) : 1052-1056.
37. Kauli R, Galatzer A, Kornreich L, Lazar L, Pertzelan A, Laron Z. Final height of girls with central precocious puberty, untreated versus treated with cyproterone acetate or GnRH analogue. A comparative study with re-evaluation of predictions by the Bayley-Pinneau method. Horm Res 1997; 47(2) : 54-61.
38. Bar A, Linder B, Sobel EH, Saenger P, DiMartino-Nardi J. Bayley-Pinneau method of height prediction in girls with central precocious puberty: correlation with adult height. J Pediatr 1995; 126(6) : 955-958.
39. Lazar L, Pertzelan A, Weintrob N, Phillip M, Kauli R. Sexual precocity in boys: accelerated versus slowly progressive puberty gonadotropin-suppressive therapy and final height. J Clin Endocrinol Metab 2001; 86(9) : 4127-4132.
40. Kelnar CJ, Stanhope R. Height prognosis in girls with central precocious puberty treated with GnRH analogues. [Commentary]. Clin Endo (Oxf) 2002; 56 : 295-296.
41. Coste J, Ecosse E, Lesage C, Chaussain JL, Carel JC. Evaluation of adolescent statural growth in health and disease: reliability of assessment from height measurement series and development of an automated algorithm. Horm Res 2002; 58(3) : 105-114.
42. Berkey CS, Dockery DW, Wang X, Wypij D, Ferris B Jr. Longitudinal height velocity standards for U.S. adolescents. Stat Med 1993; 12(3-4) : 403-414.
43. Vizmanos B, Marti-Henneberg C, Cliville R, Moreno A, Fernandez-Ballart J. Age of pubertal onset affects the intensity and duration of pubertal growth peak but not final height. Am J Hum Biol 2001; 13(3) : 409-416.
44. Biro FM, McMahon RP, Striegel-Moore R, Crawford PB, Obarzanek E, Morrison JA, Barton BA, Falkner F. Impact of timing of pubertal maturation on growth in black and white female adolescents: The National Heart, Lung, and Blood Institute Growth and Health Study. J Pediatr 2001; 138(5) : 636-643.
45. Fontoura M, Brauner R, Prevot C, Rappaport R. Precocious puberty in girls: early diagnosis of a slowly progressing variant. Arch Dis Child 1989; 64(8) : 1170-1176.
46. Palmert MR, Malin HV, Boepple PA. Unsustained or slowly progressive puberty in young girls: initial presentation and long-term follow-up of 20 untreated patients. J Clin Endocrinol Metab 1999; 84(2) : 415-423.
47. Mul D, Oostdijk W, Otten BJ, Rouwe C, Jansen M, Delemarre-van de Waal HA, Waelkens JJ, Drop SL. Final height after gonadotrophin releasing hormone agonist treatment for central precocious puberty: the Dutch experience. J Pediatr Endocrinol Metab 2000;13 Suppl 1 : 765-772.
48. Pucarelli I, Segni M, Ortore M, Arcadi E, Pasquino AM. Effects of combined gonadotropin-releasing hormone agonist and growth hormone therapy on adult height in precocious puberty: a further contribution. J Pediatr Endocrinol Metab 2003; 16(7) : 1005-1010.
49. Sorgo W, Kiraly E, Homoki J, Heinze E, Teller WM, Bierich JR, Moeller H, Ranke MB, Butenandt O, Knorr D. The effects of cyproterone acetate on statural growth in children with precocious puberty. Acta Endocrinol (Copenh) 1987; 115(1) : 44-56.
50. Beyer J, Demisch K, Wiegelmann W, Happ J, Kollmann F, Schoffling K. Cyproterone acetate in the treatment of infantile adrenogenital syndrome with precocious puberty. Acta Endocrinol Suppl (Copenh) 1973; 173 : 169.
51. Pescovitz OH, Comite F, Cassorla F, Dwyer AJ, Poth MA, Sperling MA, Hench K, McNemar A, Skerda M, Loriaux DL et al. True precocious puberty complicating congenital adrenal hyperplasia: treatment with a luteinizing hormone-releasing hormone analog. J Clin Endocrinol Metab 1984; 58(5) : 857-861.
52. Dacou-Voutetakis C, Karidis N. Congenital adrenal hyperplasia complicated by central precocious puberty: treatment with LHRH-agonist analogue. Ann N Y Acad Sci 1993; 687:250-254.
53. Soliman AT, AlLamki M, AlSalmi I, Asfour M. Congenital adrenal hyperplasia complicated by central precocious puberty: linear growth during infancy and treatment with gonadotropin-releasing hormone analog. Metabolism 1997; 46(5) : 513-517.
54. Quintos JB, Vogiatzi MG, Harbison MD, New MI. Growth hormone therapy alone or in combination with gonadotropin-releasing hormone analog therapy to improve the height deficit in children with congenital adrenal hyperplasia. J Clin Endocrinol Metab 2001; 86(4) : 1511-1517.
55. Palmert MR, Mansfield MJ, Crowley WF Jr, Crigler JF Jr, Crawford JD, Boepple PA. Is obesity an outcome of gonadotropin-releasing hormone agonist administration? Analysis of growth and body composition in 110 patients with central precocious puberty. J Clin Endocrinol Metab 1999; 84(12) : 4480-4488.
56. Heger S, Partsch CJ, Sippell WG. Long-term outcome after depot gonadotropin-releasing hormone agonist treatment of central precocious puberty: final height, body proportions, body composition, bone mineral density, and reproductive function. J Clin Endocrinol Metab 1999; 84(12) : 4583-4590. [Erratum in: J Clin Endocrinol Metab 2000; 85(2) : 657.]
57. Bertelloni S, Baroncelli GI, Sorrentino MC, Perri G, Saggese G. Effect of central precocious puberty and gonadotropin-releasing hormone analogue treatment on peak bone mass and final height in females. Eur J Pediatr 1998; 157(5) : 363-367.
58. Antoniazzi F, Zamboni G, Bertoldo F, Lauriola S, Mengarda F, Pietrobelli A, Tato L. Bone mass at final height in precocious puberty after gonadotropin-releasing hormone agonist with and without calcium supplementation. J Clin Endocrinol Metab 2003; 88(3) : 1096-1101.
59. Sigurjonsdottir TJ, Hayles AB. Precocious puberty. A report of 96 cases. Am J Dis Child 1968; 115(3) : 309-321.
60. Bovier-Lapierre M, Sempe M, David M. [Etiological, clinical and biological aspects of precocious puberty of central origin] Pediatrie 1972; 27(6) : 587-609. [Article in French]
61. Werder EA, Murset G, Zachmann M, Brook CG, Prader A. Treatment of precocious puberty with cyproterone acetate. Pediatr Res 1974; 8 (4) : 248-256.
62. Lee PA. Medroxyprogesterone therapy for sexual precocity in girls. Am J Dis Child 1981; 135(5) : 443-445.
63. Schoevaart CE, Drop SL, Otten BJ, Slijper FM, Degenhart HJ. Growth analysis up to final height and psychosocial adjustment of treated and untreated patients with precocious puberty. Horm Res 1990; 34(5-6) : 197-203.
64. Paul D, Conte FA, Grumbach MM, Kaplan SL. Long-term effect of gonadotropin-releasing hormone agonist therapy on final and near-final height in 26 children with true precocious puberty treated at a median age of less than 5 years. J Clin Endocrinol Metab 1995; 80(2) : 546-551.
65. Kauli R, Kornreich L, Laron Z. Pubertal development, growth and final height in girls with sexual precocity after therapy with the GnRH analogue D-TRP-6-LHRH. A report on 15 girls, followed after cessation of gonadotrophin suppressive therapy. Horm Res 1990; 33 (1) : 11-17.
66. Brauner R, Adan L, Malandry F, Zantleifer D. Adult height in girls with idiopathic true precocious puberty. J Clin Endocrinol Metab 1994; 79(2) : 415-420.
67. Oostdijk W, Rikken B, Schreuder S, Otten B, Odink R, Rouwe C, Jansen M, Gerver WJ, Waelkens J, Drop S. Final height in central precocious puberty after long term treatment with a slow release GnRH agonist. Arch Dis Child 1996; 75(4) : 292-297.
68. Galluzzi F, Salti R, Bindi G, Pasquini E, La Cauza C. Adult height comparison between boys and girls with precocious puberty after long-term gonadotrophin-releasing hormone analogue therapy. Acta Paediatr 1998; 87(5) : 521-527.
69. Arrigo T, Cisternino M, Galluzzi F, Bertelloni S, Pasquino AM, Antoniazzi F, Borrelli P, Crisafulli G, Wasniewska M, De Luca F. Analysis of the factors affecting auxological response to GnRH agonist treatment and final height outcome in girls with idiopathic central precocious puberty. Eur J Endocrinol 1999; 141(2) : 140-144.
70. Cassio A, Cacciari E, Balsamo A, Bal M, Tassinari D. Randomised trial of LHRH analogue treatment on final height in girls with onset of puberty aged 7.5-8.5 years. Arch Dis Child 1999; 81(4) : 329-332.
71. Klein KO, Barnes KM, Jones JV, Feuillan PP, Cutler GB Jr. Increased final height in precocious puberty after long-term treatment with LHRH agonists: the National Institutes of Health experience. J Clin Endocrinol Metab 2001; 86(10) : 4711-4716.
72. Adan L, Chemaitilly W, Trivin C, Brauner R. Factors predicting adult height in girls with idiopathic central precocious puberty: implications for treatment. Clin Endocrinol (Oxf) 2002; 56(3) : 297-302.
73. Mul D, Bertelloni S, Carel JC, Saggese G, Chaussain JL, Oostdijk W. Effect of gonadotropin-releasing hormone agonist treatment in boys with central precocious puberty: final height results. Horm Res 2002; 58 (1) : 1-7.
74. Rizzo V, De Sanctis V, Corrias A, Fortini M, Galluzzi F, Bertelloni S, Guarneri MP, Pozzan G, Cisternino M, Pasquino AM. Factors influencing final/near-final height in 12 boys with central precocious puberty treated with gonadotrophin-releasing hormone agonists. Italian Study Group of Physiopathology of Puberty. J Pediatr Endocrinol Metab 2000;13 Suppl 1 : 781-786.